Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Gastrointestinal Cancer
  •  Hematology
  •  Urological Cancers
  •  Endoscopy Methods
  •  Colorectal Cancer
  •  Colon Cancer
  •  General Oncology
  •  Blood Cancer


Citation: Clin Oncol. 2016;1(1):1089.DOI: 10.25107/2474-1663.1089

The Prognostic Value of Neutrophil-to-lymphocyte Ratio in Bladder Cancer

Won Sik Jang, Lawrence HC Kim and Kang Su Cho

Department of Urology, Urological Science Institute, Yonsei University College of Medicine, South Korea

*Correspondance to: Kang Su Cho 

 PDF  Full Text Mini Review | Open Access


In the last decade, cumulative evidence suggests that systemic inflammation is closely related to oncologic outcomes in patients with cancer. This has been demonstrated by a strong correlation between the degree of systemic inflammatory response and poor oncologic outcomes in a variety of malignancies. Several systemic inflammatory markers have been studied and, of those, neutrophilto- lymphocyte ratio (NLR) is one of the most widely used inflammatory markers. Although elevated pretreatment NLR has been reported as a useful marker associated with poor oncologic outcome in many cancers, its prognostic value in bladder cancer remains inconsistent. Therefore, this study was designed to evaluate the prognostic significance of NLR in patients with bladder cancer by reviewing published studies.


Neutrophil-to-lymphocyte Ratio; Systemic inflammation; Bladder cancer

Cite the Article:

Jang WS, Kim LHC, Cho KS. The Prognostic Value of Neutrophil-tolymphocyte Ratio in Bladder Cancer. Clin Oncol. 2016; 1: 1089.

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Genomic-wide Copy Number Variation Profile and a New IKZF1 Gene Variation in Chinese Adult Acute Lymphoblastic Leukemia
 Abstract  PDF  Full Text
Erlotinib Treatment Beyond Progression in EGFR Mutant Patients Who Have Responded to EGFR TKIs in Stage IIIB/IV NSCLC: An Open Label Randomized Trial
 Abstract  PDF  Full Text
View More...